Cramer's Mad Money - Is Best Buy the Last Man Standing? (2/13/09)

Stocks discussed on the lightning round session of Jim Cramer's Mad Money TV Program, Friday February 13.

Bullish Calls:

American Campus Communities (ACC): “I like that stock…I think that business …is bullish. I’m going to step to the plate and recommend that stock.”
Allscripts-Misys Healthcare Solutions (MDRX): “We not only like MDRX…we like CEO Glen Tulman. I think his company is uniquely set up to be a big winner…he’s addressing the privacy issue…he is on top of it…I am bullish on MDRX.”
Rayonier (RYN): “It’s a trust that spins off a lot of cash… it has a 6.8% yield…I have liked that company…I trust the yield.”
Agnico Eagle Mines (AEM): “We always default to Agnico eagle…everyone should have at least one gold position in the portfolio…that’s Agnico Eagle.”
Marathon Oil (MRO): “If you want refining, I will give you Marathon. Pull the trigger on Marathon. You won’t regret it.”

Bearish Calls:

Best Buy (BBY): “Got carried away this week because Goldman Sachs said it is going to have a huge, huge earnings because of Circuit City…even though I like the last man standing thesis, I’m going to say don’t buy.”
Dupont (DD): “I don’t trust their dividend…I’m reiterating to sell sell sell.”
Hess (HES): "The stock has a big move this week, I think it is too big…I would take profits."
Constellation Energy (CEG): “No it’s done…it’s time to take profits.”
Astec Industries (ASTE): “This happens to be a terrific way to play road building, however the stimulus package has almost nothing about road building, so I am a seller of Astec.”
Yamana (AUY): “We don’t like the way Yamana has managed the company…but the stock has had a nice run …”

Seeking Alpha publishes a summary of Jim Cramer's stock picks every day including: Mad Money Recap, Lightning Round and his Stop Trading! Picks.

Get Cramer's Picks by email-- it's free and takes only a few seconds to sign up.

Seeking Alpha is not affiliated with Jim Cramer, CNBC or TheStreet.com

Comments

[funfun:]

The struggling DuPont Company soon faces the sure and certain expiration of the patents on two DuPont drugs, Cozaar and Hyzaar, the only assets in its phased-out Pharma business. That means a looming BIG BLACK HOLE in yearly earnings of over $1 billion PTOI. Couple Pharma PTOI going "POOF!" with dramatically declining volumes resulting from a near-depression in several major DuPont markets, and the rich DD dividend of $1.64 annually is "on death row" as Allan Brochstein CFA aptly puts it! ...funfun..

Feb 16 02:50 PM